Rite Aid

Rite Aid Announces Availability of Opill at All Locations

Retrieved on: 
Thursday, April 4, 2024
General Health, Health, Retail, Pharmaceutical, Convenience Store, Pregnancy, Senior, Woman, Rite Aid, FDA, Pharmacist, OTC, Birth control

Rite Aid Corporation (OTC: RADCQ) today announced Opill, the first daily oral contraceptive FDA-approved for purchase without a prescription, is now available in all stores.

Key Points: 
  • Rite Aid Corporation (OTC: RADCQ) today announced Opill, the first daily oral contraceptive FDA-approved for purchase without a prescription, is now available in all stores.
  • Opill over-the-counter birth control pills are available at Rite Aid for the suggested retail price of $19.99 for a one-month supply and $49.99 for a three-month supply.
  • “Rite Aid remains committed to providing convenient access to customers for all of their health and wellness needs.”
    There are no restrictions for purchasing Opill.
  • Rite Aid pharmacists are available to answer any customer questions about Opill.

Diversity Research Institute to Honor Diversity First Top Companies for Diversity and their CEOs at the 20th Annual National Diversity & Leadership Conference in Dallas, TX

Retrieved on: 
Wednesday, March 13, 2024
Professional Services, Business, Human Resources, DEI (Diversity, Equity and Inclusion), Xerox, Kraft Heinz, Microsoft, Bath & Body Works, Hewlett-Packard, Rocket Mortgage, Intel, EBay, Kimberly-Clark, Bath, Conference, PG&E, The Walt Disney Company, Organization, TIAA, AES Corporation, Procter, Coca-Cola, Procter & Gamble, Uber, Health, Gilead Sciences, Edison International, Bank, Diversity, Bristol Myers Squibb, Shantanu Narayen, Avis Budget Group, Science, Rite Aid, CVS Health, Ulta Beauty, Verizon Communications, Conagra Brands, UPS, Science Applications International Corporation, BNY Mellon, DRI, Vertex Pharmaceuticals, Otis Worldwide, Omnicom Group, CDW, DEI

The companies to be honored were selected from the U.S. Fortune 500 Governance Report (2023) published by Diversity First and DRI last year.

Key Points: 
  • The companies to be honored were selected from the U.S. Fortune 500 Governance Report (2023) published by Diversity First and DRI last year.
  • The report evaluates the executive and board demographics of U.S. Fortune 500 companies.
  • It assesses racial/ethnic and gender demographics of each company according to 2019 U.S. Census Data, providing each company with a score and a ranking.
  • The DRI, in affiliation with Diversity First, lists the companies with the highest scores as Diversity First Top 50 Companies.

Rite Aid Becomes Copia’s First Retail Pharmacy Partner to Help Combat Food Waste and Support Communities

Retrieved on: 
Tuesday, March 12, 2024
Department Stores, Supermarket, Philanthropy, Food, Beverage, Health, Pharmaceutical, General Health, Retail, Foundation, Rite Aid, Partnership, Communication, Corporate Affairs, Carbon, Methane, OTC, Donation, Aid

Rite Aid (OTC: RADCQ) today announced its partnership with food surplus tracking and donation platform Copia, as it furthers its efforts to reduce waste and make a meaningful impact in the California communities it serves.

Key Points: 
  • Rite Aid (OTC: RADCQ) today announced its partnership with food surplus tracking and donation platform Copia, as it furthers its efforts to reduce waste and make a meaningful impact in the California communities it serves.
  • As the first retail pharmacy chain to partner with Copia, Rite Aid will donate food items leveraging Copia’s seamless surplus redistribution platform to easily track inventory, prove compliance, and record impact in real time.
  • The platform will match Rite Aid with local nonprofit organizations focused on combating food insecurity.
  • Food waste is one of the largest contributors to methane emissions from landfills, and by choosing to donate surplus, Rite Aid is reducing their impact on the planet,” said Kimberly Smith, CEO of Copia.

Berger Montague Announces that its False Claims Act Whistleblower Case Against CVS Health Will Move Forward to Trial

Retrieved on: 
Thursday, April 4, 2024
Element, Employment, CVS Caremark, CVS, Rite Aid, Accusative case, Federation, District court, Pharmacy, False Claims Act, CVS Health, Fraud, Caremark, Multimedia, Medicare, Government, Court, PBM, Pharmaceutical industry

PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial.

Key Points: 
  • PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial.
  • The case is brought under the False Claims Act which allows private individuals to bring claims on behalf of the government to recover for fraud against the government.
  • In its summary judgment decision, the Court rejected the CVS Health defendants' attempt to have the claims dismissed without trial.
  • We are very pleased with the Court's ruling and look forward to presenting our case to a jury at trial," said Sorensen.

Highmark Health announces Craig Riner appointment to Executive Vice President, Chief Marketing Officer

Retrieved on: 
Tuesday, March 26, 2024
Marketing strategy, Rite Aid, Highmark, Health, Allegheny Health Network, AHN, Senior, Marketing, Advertising, Management

PITTSBURGH, March 26, 2024 /PRNewswire/ -- Highmark Health today announced that Craig Riner has been appointed Executive Vice President and Chief Marketing Officer.

Key Points: 
  • PITTSBURGH, March 26, 2024 /PRNewswire/ -- Highmark Health today announced that Craig Riner has been appointed Executive Vice President and Chief Marketing Officer.
  • In this role, he will oversee marketing, brand experience, advertising and customer engagement across the entire organization, including the Highmark Health Plan, Allegheny Health Network (AHN) and its diversified businesses.
  • Previously, he served as Senior Vice President of Strategic Marketing for Highmark Health, where he oversaw all customer insights, marketing planning, campaign development, media, sponsorships, and marketing analytics across the enterprise.
  • Prior to Highmark Health, Riner was Vice President of Marketing at Rite Aid Corporation, where he led the development and launch of Rite Aid's customer loyalty program.

Pioneering Eco Haircare brand Rhyme & Reason Upgrade their High Performance Regimes with bespoke Rosemary Scalp Serum

Retrieved on: 
Thursday, March 21, 2024
Giant, CVS, Rite Aid, Serum, Social media, Kroger, Love, Scalp, Multimedia, Soil, Hydrate, Giant Eagle, Rhyme & Reason, Cosmetics

Rhyme & Reason's high-performance formulations now come with Rosemary scalp serum, to make certain that both hair and scalp are receiving the love and care they need.

Key Points: 
  • Rhyme & Reason's high-performance formulations now come with Rosemary scalp serum, to make certain that both hair and scalp are receiving the love and care they need.
  • In a recent survey conducted by Rhyme & Reason, the brand determined that 75% of US consumers felt that a healthy scalp is just as important as healthy hair**.
  • And in response, Rhyme & Reason have now made caring for both your hair & scalp super easy with shampoos & conditioners enriched with Rosemary scalp serum - proven to leave hair and scalp feeling nourished & hydrated.
  • The rosemary scalp serum does a great job at both nourishing and hydrating the scalp.

FTC Releases 2023 Privacy and Data Security Update

Retrieved on: 
Tuesday, April 2, 2024
Online, GoodRx, Consumer, Global Tel Link, Employment, Consumer protection, Algorithm, Rite Aid, Amazon Alexa, School, Epic Games, Social media, Tenant, Policy, Blog, News, AI, Fortnite, Consumer Financial Protection Bureau, Privacy, Insurance, Commission, CafePress, Housing, BetterHelp, Intelligence, Machine learning, COPPA, TransUnion, Edmodo, Collection, Parent, Advertising, FCRA, Federal Trade Commission, FTC, Cryptocurrency
Key Points: 

FTC Releases 2023 Privacy and Data Security Update

Retrieved on: 
Tuesday, April 2, 2024
Online, GoodRx, Consumer, Global Tel Link, Employment, Consumer protection, Algorithm, Rite Aid, Amazon Alexa, School, Epic Games, Social media, Tenant, Policy, Blog, News, AI, Fortnite, Consumer Financial Protection Bureau, Privacy, Insurance, Commission, CafePress, Housing, BetterHelp, Intelligence, Machine learning, COPPA, TransUnion, Edmodo, Collection, Parent, Advertising, FCRA, Federal Trade Commission, FTC, Cryptocurrency

The Federal Trade Commission released its Privacy and Data Security Update for 2023 that highlights the FTC’s work to protect consumer privacy and respond to the evolving ways that companies use consumer data such as in the development of artificial intelligence models and misuse of health data.

Key Points: 
  • The Federal Trade Commission released its Privacy and Data Security Update for 2023 that highlights the FTC’s work to protect consumer privacy and respond to the evolving ways that companies use consumer data such as in the development of artificial intelligence models and misuse of health data.
  • Between 2021 and 2023, the FTC has taken action to address privacy and security threats in several key areas including:
  • The FTC also has remained active in targeting companies that fail to implement reasonable data security measures to protect consumer data.
  • In 2022 and 2023 alone, the FTC announced or finalized enforcement actions against Global Tel*Link, Drizly, Chegg, and CafePress for data security failures.
  • In addition to vigorous enforcement, the FTC has engaged in rulemaking and other policy work to establish baseline standards that protect consumers’ privacy.

Rite Aid Enters into Agreement to Divest Majority of Health Dialog Assets

Retrieved on: 
Wednesday, March 6, 2024
Retail, Health, Convenience Store, Telemedicine, Virtual Medicine, Other Health, Pharmaceutical, Elixir, Medication, Alvarez and Marsal, Carenet Health, APA, OTC, Health Dialog, Chronic care management, Growth, Sale, Calendar, Rite Aid, Rite, Kirkland & Ellis, Organization, United States bankruptcy court, Bankruptcy, LLP, Guggenheim Partners

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced that it has entered into an asset purchase agreement (“APA”) for the partial sale of its Health Dialog business to Carenet Health (“Carenet”), a provider of healthcare engagement, clinical support, telehealth and advocacy solutions.

Key Points: 
  • Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced that it has entered into an asset purchase agreement (“APA”) for the partial sale of its Health Dialog business to Carenet Health (“Carenet”), a provider of healthcare engagement, clinical support, telehealth and advocacy solutions.
  • Health Dialog provides personalized population health solutions to improve the health of members while reducing overall medical costs for companies and organizations.
  • Rite Aid is integrating these into the Company’s clinical offerings.
  • Mr. Stein added, “Health Dialog’s clients and members will be in terrific hands with Carenet, which is a pioneer and industry leader in personalized healthcare engagement solutions.

Rite Aid and Bartell Drugs Announce Additional Dose of Updated COVID-19 Vaccine Available for Customers Ages 65 and Older

Retrieved on: 
Tuesday, March 5, 2024
Retail, Health, Convenience Store, COVID-19, Specialty, General Health, Pharmaceutical, OTC, Rite Aid, Vaccination, ACIP, Aid, Senior, Pharmacist, CDC, Pacific Northwest, Vaccine

Rite Aid (OTC:RADCQ) recently announced that appointments are now available for eligible customers ages 65 and older seeking an additional dose of the updated COVID-19 (2023-2024) vaccines at its locations, including Bartell Drugs locations in the Pacific Northwest.

Key Points: 
  • Rite Aid (OTC:RADCQ) recently announced that appointments are now available for eligible customers ages 65 and older seeking an additional dose of the updated COVID-19 (2023-2024) vaccines at its locations, including Bartell Drugs locations in the Pacific Northwest.
  • “Rite Aid wants to ensure our customers safeguard their health, especially those in vulnerable populations, including our customers ages 65 and older.”
    The updated COVID-19 vaccine provides enhanced protection against currently circulating variants of COVID-19.
  • According to the new recommendation, all customers ages 65 and older who previously received the COVID-19 vaccine (2023-2024) should receive an additional dose four months after receipt of the prior dose.
  • Rite Aid pharmacists are trained to immunize customers ages three and older based on the CDC's vaccine guidelines and state regulations.